secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001493152-23-032103
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa receives Nasdaq notice for non-compliance with minimum MVPHS of $5M
---------------------------------------------------------------------------

- Nasdaq letter dated Sept 1, 2023 for failure to meet minimum Market Value of Publicly Held Shares of $5M.
- Company has 180 calendar days, until Feb 28, 2024, to regain compliance by closing MVPHS ≥$5M for 10 consecutive business days.
- Failure to regain compliance could lead to delisting; company may consider transfer to Nasdaq Capital Market.
- Common stock continues to trade on Nasdaq Global Market under symbol ZVSA with no immediate effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223032103/0001493152-23-032103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315223032103/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-032103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer